{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:11:15Z","timestamp":1793329875418,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T00:00:00Z","timestamp":1674259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ahj.2023.01.007","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T02:22:55Z","timestamp":1673576575000},"page":"77-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial"],"prefix":"10.1016","volume":"258","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1644-2079","authenticated-orcid":false,"given":"Christian","family":"Spaulding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krackhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Bogaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Meis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Morice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Eccleshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2023.01.007_bib0001","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2013.04.011","volume":"8","author":"Serruys","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.01.007_bib0002","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.jacc.2020.12.059","article-title":"10-year follow-up of patients with everolimus-eluting versus bare-metal stents after st-segment elevation myocardial infarction","volume":"77","author":"Brugaletta","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.01.007_bib0003","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2019.11.058","article-title":"Stent-related adverse events >1 year after percutaneous coronary intervention","volume":"75","author":"Madhavan","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.01.007_bib0004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcin.2016.10.027","article-title":"Very late scaffold thrombosis of bioresorbable vascular scaffold: systematic review and a meta-analysis","volume":"10","author":"Toyota","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.01.007_bib0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016224","article-title":"Clinical and angiographic outcomes with drug-coated balloons for de novo coronary lesions: a meta-analysis of randomized clinical trials","volume":"9","author":"Elgendy","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2023.01.007_bib0006","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(18)31719-7","article-title":"Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial","volume":"392","author":"Jeger","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.01.007_bib0007","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.jcin.2020.08.035","article-title":"Drug-coated balloon versus drug-eluting stent for small coronary vessel disease: PICCOLETO II randomized clinical trial","volume":"13","author":"Cortese","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.01.007_bib0008","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.4244\/EIJ-D-19-00723","article-title":"Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial","volume":"15","author":"Scheller","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2023.01.007_bib0009","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00392-020-01734-6","article-title":"Long-term safety of paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease: the SPARTAN DCB study","volume":"110","author":"Merinopoulos","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ahj.2023.01.007_bib0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jacc.2015.04.063","article-title":"A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the ribs iv randomized clinical trial","volume":"66","author":"Alfonso","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.01.007_bib0011","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jcin.2018.11.040","article-title":"Treatment of coronary drug-eluting stent restenosis by a sirolimus- or paclitaxel-coated balloon","volume":"12","author":"Ali","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.01.007_bib0012","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(12)61964-3","article-title":"Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial","volume":"381","author":"Byrne","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2023.01.007_bib0013","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4244\/EIJ-D-17-01079","article-title":"Angiographic and clinical performance of a paclitaxel-coated balloon compared to a second-generation sirolimus-eluting stent in patients with in-stent restenosis: the BIOLUX randomised controlled trial","volume":"14","author":"Jensen","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2023.01.007_bib0014","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jcin.2017.04.024","article-title":"Neointimal modification with scoring balloon and efficacy of drug-coated balloon therapy in patients with restenosis in drug-eluting coronary stents: a randomized controlled trial","volume":"10","author":"Kufner","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.01.007_bib0015","article-title":"Comparison of the efficacy of paclitaxel-eluting balloon catheters and everolimus-eluting stents in the treatment of coronary in-stent restenosis: the treatment of in-stent restenosis study","volume":"9","author":"Pleva","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.01.007_bib0016","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jacc.2012.01.015","article-title":"A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study","volume":"59","author":"Rittger","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2023.01.007_bib0017","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1161\/CIRCULATIONAHA.108.839282","article-title":"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis","volume":"119","author":"Unverdorben","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.01.007_bib0018","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa061254","article-title":"Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"355","author":"Scheller","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.01.007_bib0019","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4244\/EIJV9I5A98","article-title":"Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial","volume":"9","author":"Waksman","year":"2013","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2023.01.007_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6548696","article-title":"Drug coated balloon-only strategy in de novo lesions of large coronary vessels","volume":"2019","author":"Rosenberg","year":"2019","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.ahj.2023.01.007_bib0021","first-page":"181","article-title":"Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions: The DCB-only All-Comers Registry","volume":"93","author":"Rosenberg","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.01.007_bib0022","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2459\/JCM.0000000000000806","article-title":"Angiographic performance of a novel sirolimus-coated balloon in native coronary lesions: the FAtebenefratelli SIrolimus COated NATIVES prospective registry","volume":"20","author":"Cortese","year":"2019","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.ahj.2023.01.007_bib0023","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2459\/JCM.0000000000001070","article-title":"Clinical performance of a novel sirolimus-coated balloon in coronary artery disease: EASTBOURNE registry","volume":"22","author":"Cortese","year":"2021","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.ahj.2023.01.007_bib0024","first-page":"E317","article-title":"Long-term efficacy of drug coated balloons compared with new generation drug-eluting stents for the treatment of de novo coronary artery lesions","volume":"92","author":"Venetsanos","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.01.007_bib0025","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.103.18.2289","article-title":"Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis","volume":"103","author":"Heldman","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2023.01.007_bib0026","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jcin.2013.04.013","article-title":"Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model","volume":"8","author":"Buszman","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.01.007_bib0027","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1056\/NEJMe058140","article-title":"Healing Achilles-Sirolimus versus Paclitaxel","volume":"353","author":"Moliterno","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2023.01.007_bib0028","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.01.007_bib0029","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(20)32173-5","article-title":"Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial","volume":"396","author":"Jeger","year":"2020","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ahj.2023.01.007_bib0030","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4244\/EIJY19M01_01","article-title":"ESC\/EACTS Guidelines on myocardial revascularization","volume":"14","author":"Neumann","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2023.01.007_bib0031","first-page":"544","article-title":"Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: rationale and design of the TRANSFORM II randomized clinical trial","volume":"100","author":"Greco","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2023.01.007_bib0032","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.carrev.2022.08.037","article-title":"Sirolimus-coated balloon with a microsphere-based technology for the treatment of de novo or restenotic coronary lesions","volume":"45","author":"Costa","year":"2022","journal-title":"Cardiovasc Revasc Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870323000108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:10:53Z","timestamp":1757571053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870323000108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":32,"alternative-id":["S0002870323000108"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2023.01.007","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2023.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}